Skip to main content

Financial News

  • Pfizer could lose No. 1 global sales ranking to Sanofi next year, report finds

    LONDON — Pfizer soon may lose its distinction of having the highest global sales of any drug company, according to life sciences industry analysis firm EvaluatePharma.

    The next contender for the title is France's Sanofi, which EvaluatePharma said was expected to take the top spot next year and stay there through 2016.

  • Impax reports sales, profit increases in third quarter

    HAYWARD, Calif. — Drug maker Impax Labs reported sales of $119.8 million and profits of $20 million in third quarter 2011, according to an earnings report released Tuesday.

    The latest sales figures represented a $12.2 million increase over third quarter 2010, while profits were $4.2 million higher.

  • Winn-Dixie posts consecutive quarterly same-store sales increases

    JACKSONVILLE, Fla. — Winn-Dixie's transformational remodel initiative is setting the stage for a strong 2012, the company reported Tuesday morning during its first-quarter conference call.

  • Watson sales, profits surge in Q3

    PARSIPPANY, N.J. — Watson Pharmaceuticals had sales of $1.1 billion and profits of $68.1 million in third quarter 2011, the drug maker said in an earnings statement Tuesday.

    The latest figures compared with sales of $882.4 million and profits of $25.7 million in third quarter 2010, the company said. For the first nine months of 2011, sales were $3.04 billion and profits were $166.1 million, compared with sales of $2.61 billion and profits of $166.1 million in the first nine months of 2010.

  • Implus acquired by Trilantic Capital; foot care co. poised for growth

    NEW YORK — Trilantic Capital Partners, a global private equity firm, on Tuesday announced that it has partnered with management to acquire Implus, a leader in the footwear, outdoor and fitness accessories markets. Financial terms of the transaction were not disclosed.

  • Publix reports Q2 results and stock price

    LAKELAND, Fla. — Publix on Monday reported sales of $6.6 billion for the second quarter, a 5.8% increase. Comparable-store sales for second quarter 2011 increased 4.2%.

    Earnings per share for the second quarter increased to 48 cents for 2011, up from 44 cents per share in 2010.

    Effective Aug. 1, 2011, Publix’s stock price increased from $21.65 per share to $22.05 per share. Publix stock is not publicly traded and is made available for sale only to current Publix associates and members of its board of directors.

  • Vitamin Shoppe confirms plans to open 48 stores in fiscal year

    NORTH BERGEN, N.J. — Vitamin Shoppe said during its second-quarter earnings release that it is on track to open 48 stores in the fiscal year.

    The chain opened its 500th store, located in St. Peters, Mo., in April.

    On Thursday, Vitamin Shoppe reported that its net income rose 64% to $11.6 million in the quarter, compared with $7.3 million in the year-ago period. The retailer cited strong sales both in-store and online for its improved performance.

  • McKesson's rollout of enhanced solutions will benefit from strong Q1

    SAN FRANCISCO — A little less than a month following the company's IdeaShare 2011 conference held here, McKesson reported a strong first-quarter headwind that will help support many of the initiatives announced at the show, particularly for its Health Mart independent pharmacy group.

X
This ad will auto-close in 10 seconds